Closed · W81XWH-09-PCRP-PBIDA · CFDA 12.420 · Discretionary

FY09 DOD Prostate Cancer Population-based Idea Development Award

Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.

Varies
Award range
Closed
Status
May 20, 2009
Close date
3
Expected awards

The verdict

FY09 DOD Prostate Cancer Population-based Idea Development Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 3 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,795 other opportunities from Defense Health Agency Contracting Activity - DHACA.

Varies
award range
Closed
application status
3
expected awards
12.420
CFDA program

Archived opportunity record

FY09 DOD Prostate Cancer Population-based Ide… is closed (last close May 20, 2009). Check the agency catalog for replacement NOFOs. Defense Health Agency Contracting Activity - DHACA still indexes 1,795 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed May 20, 2009

Posted Feb 11 Closes May 20

Est. Total Funding

$2,900,000

Expected Awards

3

Instrument

Grant

Description

The PCRP Population-Based Idea Development Award mechanism supports innovative high-impact approaches to prostate cancer research that will contribute significantly to the prevention, detection, diagnosis, and/or treatment of prostate cancer or greatly enhance the quality of life for prostate cancer patients. The overall goal of this award is to generate unique information and/or tools that can only be achieved from the perspective of population statistics. The PCRP seeks applications from all areas of population-based studies including but not limited to population genomics, meta-analysis, prospective and/or retrospective analyses, diet, exercise, survival, population surveillance, etc., with specific relevance to prostate cancer, that are responsive to one or more of the FY09 PCRP focus areas. NOTE: Clinical trials are not allowed under this mechanism. Refer to the Application Instructions and General Information, Appendix 6, for helpful information about distinguishing clinical trials and clinical research. It is the responsibility of the Principal Investigator (PI) to clearly and explicitly articulate how the project addresses the following important aspects of the Population-Based Idea Development Award: 1. Innovation: Innovative research may represent a new paradigm, challenge existing paradigms, or look at existing problems from new perspectives. This may include high-risk approaches to prostate cancer provided that there is potential for significant impact. Research that is an incremental advance upon published data is not considered innovative and will not be considered for funding under this mechanism. 2. Impact: Research that has high impact will, if successful, significantly advance current methods and concepts for the prevention, detection, diagnosis, or treatment of prostate cancer in humans. 3. Responsiveness to FY09 PCRP focus areas: The relevance of the research problem to one or more of the focus areas. 4. Preliminary Data: Submission of preliminary data relevant to prostate cancer and the proposed project is encouraged but not required. Any preliminary data provided should be from the laboratory of the PI or member(s) of the collaborating team. Although groundbreaking research often involves a degree of risk due to unforeseen difficulties or results, applications should be based on a sound scientific rationale that is established through logical reasoning and/or critical review and analysis of the literature. See the Program Announcement for the full Funding Opportunity Description.

Catch-all / unrestricted eligibility mark · W81XWH-09-PCRP-PBIDA

Grants.gov marks FY09 DOD Prostate Cancer Population-based Ide… with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the Defense Health Agency Contracting Activity - DHACA book (1,791 peers, 100% of 1,796).

Code 99
Unrestricted / see official listing

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org

What to do next

FY09 DOD Prostate Cancer Population-based Ide… is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 12.420 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Compare award ranges across federal categories before you pick a single CFDA. All categories

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants